Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 11639

Edit search filters
  1. Sequencing for Families with Hereditary Disorders

    Rochester, MN

  2. Phase 1/2a Clinical Trial Of PR001 (LY3884961) In Patients With Parkinson's Disease With At Least One GBA1 Mutation (PROPEL)

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Eosinophilic Esophagitis Pilot Trial of Baked Milk Tolerance

    Rochester, MN

  4. A Study to Evaluate Obinutuzumab to Treat Immunosuppression-dependent or Immunosuppression/Treatment-resistant Focal Segmental Glomerulosclerosis

    Rochester, MN

  5. Submandibular Gland Needle Core Biopsy and Skin Punch Biopsy as Tissue Biomarkers for the Diagnosis and Monitoring of Disease Progression of Parkinson’s Disease and REM Sleep Behavior Disorder

    Scottsdale/Phoenix, AZ

  6. Visionary Study: Phase 3 Trial Of Sibeprenlimab In Immunoglobulin A Nephropathy (IgAN)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. A Study Of HFB200301 In Adult Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study To Assess The Long-Term Safety And Efficacy Of Eplontersen (Formerly Known As ION-682884, IONIS-TTR-LRx And AKCEA-TTR-LRx) In Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Scottsdale/Phoenix, AZ

  9. A Study To Assess The Safety And Tolerability Of Single And Multiple Doses Of KAN-101 In Celiac Disease Patients

    Rochester, MN

  10. Protonix Treatment Of Maintenance Of Healing In Pediatric Participants Aged 1-11 Years And 12-17 Years

    Rochester, MN

.

Mayo Clinic Footer